ical changes with the objective of answering five specific questions: 1) Is there a problem with end-of-life care in the ICU? 2) What is the epidemiology of death in the ICU? 3) How does one explain the differences between and within countries and cultures regarding end-of-life care? 4) Who decides to limit life-sustaining treatments in the ICU? 5) What is the optimal care for patients dying in the ICU? A document synthesizing the experts' opinion, the available literature, and 2 days of deliberation by the jury was prepared by jury members. The following is an executive summary of that document.
The full text with references is available in the May 2004 issue of Intensive Care Medicine.
QUESTION 1: IS THERE A PROBLEM WITH END-OF-LIFE CARE IN THE ICU?
The jurors answered this question in the affirmative. Problematic areas included variability in end-of-life practice, inadequate predictive models for death in the ICU, elusive knowledge of patients' preferences, poor communication between ICU staff and surrogates, insufficient or absent training of healthcare providers in end-of-life care, the use of imprecise and insensitive terminology, and incomplete documentation in the medical record.
Wide variability in the frequency with which decisions are made to forgo lifesustaining treatments and the process surrounding it is apparent not only from country to country but also between ICUs in the same country. There are also obvious discrepancies between the widely agreed and approved recommendations of scientific societies and daily practice. Although the lack of a consensual approach may not necessarily be a problem, a common challenge is to avoid over-treatment while avoiding precipitous decisions to withdraw treatment that could lead to potentially avoidable deaths.
It is often difficult to determine the preferences of individual patients, and patients' preferences may change over time with changing circumstances. Less than 5% of ICU patients retain decisionmaking capacity (1) . There is evidence to suggest that patients do not always receive the care they desire or would have wished to receive (2) . Most patients have not completed advance written (instructive) directives, and knowledge and un-derstanding of the patients' life-support preferences among the family, clinicians, and nurses is often poor (3). This may be compounded by misunderstandings related to the cultural, spiritual, and religious needs of patients and their families (4 -6) .
Compelling evidence indicates that communication between ICU staff and family members may be problematic. Families consistently rate communication with the ICU staff as being among their most important concerns.
Finally, the jury concluded that who makes the decision on the forgoing of life-sustaining treatments and how these decisions are made are serious, unresolved problems. There is considerable variation between countries in the relative roles played by doctors, nurses, and families in the decision-making process.
QUESTION 2: WHAT IS THE "EPIDEMIOLOGY" OF DEATH IN THE ICU?
Studying death and dying in ICUs is fraught with difficulties: nonuniform definitions, invalidated survey instruments, incomplete administrative data or data that is otherwise qualitative, poor documentation in the medical record, and differing populations of interest (e.g., all ICU admissions vs. all ICU deaths). However, what is common to all studies is that they deal with a population that shares the acknowledgment/medical consensus that further aggressive care is unlikely to be beneficial. Indeed, they also share a final common pathway to death.
Despite the difficulties facing investigators, the number of publications dealing with this topic is significant and expanding. Current data suggest that 20% of all patients dying in the United States die in an ICU (7) . There is an increasing recognition of the need to change from a curative to a comfort philosophy of care in a certain subset of patients. In a North American study during the 5-yr period from 1988 to 1992, the percentage of patients dying following a decision to withhold or withdraw life-sustaining treatments had increased from 51% to 90% (8) .
Studies in a number of European countries have also demonstrated the increasing number of patients in ICUs for whom curative care is unlikely to succeed and therapy is limited and that there are substantial (regional or local) differences in the practice of forgoing life-support treatment (9) . It is important to emphasize, however, that is it is not so much the variation in practice that is important in this context as the changing and increasing incidence of the practice of limiting life-sustaining care at the end of life.
There is a great deal of data describing the process of withdrawal of life support both from a mechanistic and an effect perspective. In essence, these data emphasize that the process must respect the dignity of the patient and ensure the wellbeing of family and caregivers. How effectively this approach optimizes and humanizes the dying process is probably best measured by the degree of satisfaction of the family and the healthcare team.
What emerges from reviewing the data is that although in practice the approach to end-of-life care is often inconsistent, there is general agreement as to what, ideally, should be done. We should accept and recognize these differences and not strive for equal "quantity" but rather strive for exceptional "quality" in end-oflife care.
QUESTION 3: HOW DOES ONE EXPLAIN THE DIFFERENCES BETWEEN AND WITHIN COUNTRIES AND CULTURES REGARDING END-OF-LIFE CARE?
That there are significant differences between end-of-life care in Europe and North America, as well as wide variations between and within countries and between individual units, is not in doubt. Whereas many differences exist, the major ones relate to discrepancies in the rates of withdrawing and withholding treatments, the frequency with which ICU admission is refused, and the proportion of ICU deaths preceded by do-notresuscitate orders.
It is, however, easier to document the differences than to explain them. Although it has been suggested that individual, professional, societal, and cultural issues, among others, offer an explanation, there is little evidence to support this contention.
In the United States, respect for patient autonomy is now paramount and the patient here has an unambiguous right to refuse life-prolonging therapy. Physicians have an obligation to respect this right. Although most European legislation has not specifically addressed the issue of forgoing life support in the terminally ill, there is increasing concern that widely accepted medical practices in end-of-life care might not be supported by the courts. However, the legal climate in Europe appears to be evolving and the European Commission has recently ruled that the patient has the right of self determination, including the right to refuse unwanted therapies. In addition, laws pertaining to patients' rights have also been proposed in France and Belgium, which state explicitly that doctors must respect the refusal of care by competent patients. At the same time, a convergence of opinion about good practice at the end of life appears to be developing among professional societies in the United Kingdom and Europe. In this regard, clinicians should anticipate and properly manage the majority of deaths in the ICU.
Despite this encouraging degree of agreement, there is an important trans-Atlantic divergence as to who has the final decision if the patient is incompetent. Guidelines from the United Kingdom and other professional societies in Europe clearly indicate that this responsibility lies with the doctor in charge of the patient's care. By contrast, although the three professional societies in the United States (American Thoracic Society, Society of Critical Care Medicine, and American College of Chest Physicians) strongly support the shared decisionmaking model, none of the three advocate that the primary or ultimate decision should rest with clinicians.
Most societies are increasingly multicultural and multiracial, with a diversity of religious beliefs, and deficiencies in end-of-life care tend to be more pronounced in ethnic minority populations. Recognizing this pluralism is, therefore, fundamental to the provision of highquality end-of-life care. What constitutes a good or bad death is largely based on the individual opinions of those involved, which may be strongly influenced by their ethnicity, culture, and religion.
QUESTION 4: WHO DECIDES TO LIMIT LIFE-SUSTAINING TREATMENT IN THE ICU?
The overriding goal for all involved parties should be to act in the patient's best interests. The decision to limit lifesustaining treatments in the ICU should be based on widely held ethical principles, such as autonomy, beneficence, nonmaleficence, and distributive justice.
Reasons for limiting, withholding, or withdrawing therapy may, therefore, include patient refusal, the unlikelihood that a patient will benefit from a therapy because of a poor prognosis, or the failure of a therapy to improve a patient's condition after a reasonable trial. The patient's desires and values should guide the process.
Although the principle of patient autonomy designates the patient as the ultimate decision maker, this cannot be applied to the majority of patients dying in the ICU, because fewer than 5% have sufficient mental competency to make their own decisions and only 10% have prepared advance directives. Decision making often then falls to surrogates. However, surrogates often fail to represent accurately the patient's wishes, and family members of dying patients have high rates of anxiety and depression, perhaps compromising their decision-making capability.
Although the attending clinician is ultimately responsible for the patient's medical care in the ICU and is clearly in the best position to assess a response to therapy and prognosis, he or she should not be the sole decision maker. Other clinicians involved in the care of patients in the ICU should also participate in endof-life decision making to ensure an objective opinion.
The Decision-Making Process
The Ideal. Despite the perceived dichotomy between the autonomous North American approach to end-of-life decision making and the more paternalistic approach of European countries, the United States and some European countries have been moving toward the "shared decision" paradigm, a movement that has been stimulated, in part, by studies showing that patients want their families to act as surrogates in the event they become mentally incompetent and that many favor joint decision making with the clinicians.
We advocate a "shared" approach to end-of-life decision making, which is a dynamic process with responsibility for the decision being shared between the caregiver team and patient surrogates. The purpose is to reach consensus on a process that is in accordance with the patient's values while providing comfort and support to the family and surrogates. The process should begin early during the ICU admission, with a meeting to inform families about their loved ones' illness and of the possible need to limit care should there be lack of improvement or further deterioration. Subsequent meetings are held as needed to update families on the patients' condition and to discuss end-of-life issues.
The meetings should be multidisciplinary, use nontechnical language, and allow ample time for questions and consideration of the patients' personal values and goals of therapy. The process is one of negotiation. The outcome will be determined by the personalities and beliefs of the participants, and ideally, all should be involved in the decision, culminating in shared agreement. Documentation of the meeting is extremely important so that there is a record of the proceedings and a reference should questions arise in the future.
Ultimately, it is the attending physician's responsibility, as leader of the healthcare team, to decide on the reasonableness of the planned course of action. In the event of conflict, the ICU team may agree to continue support for a predetermined interval of time, following which the situation will be reassessed with the family. Most conflicts can be resolved and unrealistic requests from the family minimized if discussions focus on goals, prognoses, and treatment options from an early stage and if the parties understand and trust one another. If the conflict persists, however, an ethics consultation may be helpful in bringing resolution. The key to success with the "shared decision" model is communication.
The Reality. Numerous studies have shown wide variability in the degree to which families are involved in end-of-life discussions. Studies conducted in French ICUs found that families were involved in end-of-life decisions in only 44% and 17% of cases, whereas a European survey found major differences in the behavior of clinicians practicing in northern vs. southern Europe (10, 11) . Thus, the reality is far from the ideal. In addition, the jury acknowledges that there is considerable variability between individual physicians, even in the same institution, regarding end-of-life decisions and that in some instances, religious, cultural or legal issues may be overriding. However, we advocate a movement toward the shared decision-making paradigm described above as one that injects more balance into the process and best serves the interests of the patient, as well as underlying ethical principles.
QUESTION 5: WHAT IS THE OPTIMAL CARE FOR PATIENTS DYING IN THE ICU?
Optimal care for patients, both living and dying, in the ICU involves focusing from the very beginning on comfort, as well as cure. The goal is achievement of the best possible quality of life for patients and their families. When caring is central to the philosophy of ICU management from the beginning, then good endof-life care becomes an intrinsic attribute of intensive care. Rather than thinking in terms of "withdrawing" or "withholding" therapies, we can think in terms of "shifting from cure to comfort care."
Comfort care has several essential dimensions: physical, social, and spiritual. First and perhaps foremost, the patient must be assured of a pain-free death. We subscribe to the moral and legal principles that prohibit administering treatments specifically designed to hasten death. The patient must be given sufficient analgesia to alleviate pain and distress; if such analgesia hastens death, this "double effect" should not detract from the primary aim to ensure comfort. During the process of withdrawal of intensive treatments, the surrogate or family member's perceptions about the patient's level of pain or distress should be sought and this perception may assist the ICU team's titration of analgesic and sedative dosing for the provision of a good death.
For optimal care, the ICU should work as a team. Nurses must be involved in the shared decision-making process. They should be encouraged to voice concerns about specific patients and procedures; it is important that nurses' rapport with families be appreciated and supported, because the comfort and satisfaction of the family during the dying process often depends on this relationship. Trainee doctors must be encouraged to work with nurses and senior medical staff to offer informed concerned care to patients and families.
When we perceive patients as being enmeshed in a web of social and familial relationships, it is then easier to appreciate that death will sever these significant connections. For optimal care, the team must feel responsible for the well-being of the family, as well as the patient. As noted above, the family must be informed and involved in working with the team and must be helped to feel they are not alone. Families who indicate the desire to do so may be involved in the decisionmaking process but should never be given the sole responsibility, or the sole burden, for making what are ultimately clinical and difficult decisions.
The success of the "shared decision" model depends on the willingness, abilities, and availability of the ICU team to make time for these discussions: an institutional commitment to supply adequate numbers of physicians, nurses, and other personnel and to assist with their training is, therefore, a prerequisite.
We strongly recommend that research be initiated, conducted, and founded to improve end-of-life care and to teaching effective methods to trainees. Research is also needed to delineate the optimal approach to the decision-making process to best serve patients' interests and to maximize satisfaction among families and caregivers. As David Kuhl observed at the International Consensus Conference on Challenges in End-of-Life Care in the ICU, "ours is a death-denying society," and "ours is a death denying profession." One of our greatest challenges is learning to regard dying as a normal process. Doctors must learn to feel at home with the concept of death, to help patients achieve a death with dignity. To quote Cicely Saunders, "The dying need the friendship of the heart-its qualities of care, acceptance, vulnerability; but they also need the skills of the mind-the most sophisticated treatment that medicine has to offer." Intensive care physicians have all been given superb training in the skills of the mind. For optimal care, they must learn to offer the crucial "friendship of the heart."
